Sun Biomedical (SBN)

Shares / Stock Code

SBN

Stock Exchange / Sharemarket

Australian Securities Exchange

Sun Biomedical (SBN) is a developer of law enforcement and homeland security products and solutions. The company is developing two main products - ShockRounds™ electrified projectiles and a totally portable Substance Abuse Testing (SAT) system, which enables on-the-spot testing of up to six illicit drugs. It’s marquee product is the world leading OraLine saliva drug screening product which is regarded as the most advanced saliva drug screen product on the market today. Sun Biomedical is an Australian public company listed on the Australian stock market.

The Harrington group was listed on the Australian Stock Exchange (ASX) in 1993. The company's head office is based in Perth, WA. The company also operates out of California. The company was renamed to its current name in December 2007.

Sun Biomedical's differentiating factor is it's ShockRounds™ technology, which introduces an electric charge to traditional ammunition and other projectiles such as rubber bullets. There is a considerable body of evidence that shows that voltages from this technology can incapacitate with minimal or no long-term side effects. The Company has also partnered up with SunBiomedical to produce cutting edge technology for drug screening products.

SBN's major competitors include other developers of law enforcement technologies, that operate both within Australia and globally. Its main customers include law enforcement agencies, such as the police, and the military industry. The Company’s subsidiaries include MDM Technologies Pty Ltd, HGR USA Inc., Sun Biomedical laboratories Inc. and Sum Biomedical Australia Pty Ltd. As of April 30, 2009, the Company focused on evaluating a number of new investment opportunities.

Sun Biomedical (SBN) Products and Services

  • Developer of law enforcement and homeland security products and solutions.

Sun Biomedical (SBN) Locations and Subsidiaries

Sun Biomedical Head Office
TressCox Lawyers, Level 9, 469 La Trobe Street,
MELBOURNE, VIC, AUSTRALIA, 3000
Phone: 1300 850 505
Fax: 03 9473 2500

Sun Biomedical (SBN) Share Price

Submitted by ASX Listed Company on 3 June, 2010 - 20:30